BridgeMD
New treatment option for Premature Birth
Official title Physiologically Based Cord Clamping To Improve Neonatal Outcomes In Moderate And Late Preterm Newborns
ClinicalTrials.gov ID: NCT06280872
What this study is testing
- What it's testing
- Before birth, the baby's lungs are filled with fluid and babies do not use the lungs to breathe, as the oxygen comes from the placenta. As delivery approaches, the lungs begin to absorb the fluid.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 32 to 36
You may be able to join if
- Pregnant women followed-up in Brugmann University Hospital will be eligible to participate if:
- The delivery takes place between 32 0/7 and 36 6/7 weeks of gestation
- They carry singletons
You likely can't join if
- Fetal anomalies including congenital malformations, anemia, and growth restriction with abnormal Dopplers.
- Abnormal placentation such as placenta previa.
- Signs of fetal distress necessitating an emergency cesarean section.
- Maternal health issue including severe anemia (defined as hemoglobin level \< 7 g/dL), preeclampsia, and bleeding disorders.
- Maternal refusal of the use of blood products.
- General anesthesia for cesarian section.
See the full eligibility criteria
- Pregnant women followed-up in Brugmann University Hospital will be eligible to participate if:
- The delivery takes place between 32 0/7 and 36 6/7 weeks of gestation
- They carry singletons
- Fetal anomalies including congenital malformations, anemia, and growth restriction with abnormal Dopplers.
- Abnormal placentation such as placenta previa.
- Signs of fetal distress necessitating an emergency cesarean section.
- Maternal health issue including severe anemia (defined as hemoglobin level \< 7 g/dL), preeclampsia, and bleeding disorders.
- Maternal refusal of the use of blood products.
- General anesthesia for cesarian section.
- Planned cord blood banking.
- Total language barrier without possibility of translation
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 32 weeks to 36 weeks. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.